Mar 27, 2026
Gilbert Cisneros- Amount
- $50,001 to $100,000
- Filed
- Date not disclosed
Congress ticker disclosure profile
As of August 4 at 9:02 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference CATY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
4
Disclosed ranges
$131K
Most active member desks
6 sells vs 5 buys
Latest trade Mar 27, 2026
Mar 27, 2026
Gilbert CisnerosMar 3, 2026
Gilbert Ray Cisneros Jr.Jan 15, 2026
Gilbert Ray Cisneros Jr.Apr 9, 2025
Josh GottheimerOct 16, 2020
Josh GottheimerSep 15, 2020
Josh GottheimerAug 15, 2019
Gilbert CisnerosJun 24, 2019
Donna ShalalaMar 25, 2019
Nicholas Van TaylorFeb 20, 2019
Donna ShalalaMay 18, 2018
Josh Gottheimer| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 27, 2026 | Gilbert Cisneros | Sell | $50,001 to $100,000 | Date not disclosed | Open card |
| Mar 3, 2026 | Gilbert Ray Cisneros Jr. | Buy | $1,001 to $15,000 | Apr 7, 2026 | Open card |
| Jan 15, 2026 | Gilbert Ray Cisneros Jr. | Buy | $1,001 to $15,000 | Feb 13, 2026 | Open card |
| Apr 9, 2025 | Josh Gottheimer | Sell | $1,001 to $15,000 | May 14, 2025 | Open card |
| Oct 16, 2020 | Josh Gottheimer | Buy | $1,001 to $15,000 | Nov 5, 2020 | Open card |
| Sep 15, 2020 | Josh Gottheimer | Sell | $1,001 to $15,000 | Oct 13, 2020 | Open card |
| Aug 15, 2019 | Gilbert Cisneros | Buy | Receipt pending ingestion | Sep 11, 2019 | Open card |
| Jun 24, 2019 | Donna Shalala | Sell | $1,001 to $15,000 | Apr 27, 2020 | Open card |
| Mar 25, 2019 | Nicholas Van Taylor | Sell | Receipt pending ingestion | Apr 15, 2019 | Open card |
| Feb 20, 2019 | Donna Shalala | Buy | $1,001 to $15,000 | Apr 27, 2020 | Open card |
| May 18, 2018 | Josh Gottheimer | Sell | Receipt pending ingestion | Oct 2, 2018 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 8 of 11 filed rows include disclosed amount ranges (73%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.